Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (31 ops.)
Latest filing published 05 Mar 2025 for ALNYLAM PHARMACEUTICALS, INC..
Filing timeline
BuySaleRobert W. Hesslein
Insider track record
Disclosed buys
0
Disclosed sells
31
Signal history
Robert W. Hesslein: trading record in brief
Thirty-one sales, but small ones: the median for Robert W. Hesslein is EUR 25,304, for a total of EUR 2,346,244. Only one clearly exceeds the rest, EUR 944,497 on January 16, 2018 at Foundation Medicine, Inc., ahead of EUR 295,808 on July 2, 2018 and EUR 183,775 on March 16, 2017. No purchase is recorded.
The history runs over 48 filings published from April 6, 2016 to March 5, 2025 and touches three US companies: Foundation Medicine, Inc. (28, title SVP and General Counsel), Voyager Therapeutics, Inc. (18, Senior VP & General Counsel) and Alnylam Pharmaceuticals, Inc. (2, EVP, CLO and Secretary). The year 2017 holds 13 filings, 2018 has 9, while 2024 and 2025 have one each. There are also 10 share grants, 5 option exercises and 2 lines of another nature.
Trades by Hesslein within 30 days of colleagues at Foundation Medicine, Inc. number 18, 17 and 17, every one in the same direction. Names in order: Jason Ryan, Michael J. Pellini and Vincent A. Miller.
Companies and markets linked to Robert W. Hesslein
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations48 total
757 shares0Common StockSEC:0001735276-25-000035:0
7,245 shares0Common StockSEC:0001735276-24-000096:0
4,410 shares@ US$7.7619.1% of flowCommon StockSEC:0001104659-23-035638:0
3,297 shares@ US$7.4513.7% of flowCommon StockSEC:0001104659-23-024424:0
2,868 shares@ US$7.6712.3% of flowCommon StockSEC:0001104659-23-022429:0
792 shares@ US$10.343.2% of flowCommon StockSEC:0001104659-23-005053:1
1,396 shares@ US$9.577.3% of flowCommon StockSEC:0001104659-23-005053:0
2,786 shares@ US$8.2512.5% of flowCommon StockSEC:0001104659-22-043244:0
58 shares@ US$8.680.2% of flowCommon StockSEC:0001104659-22-037153:1
4,897 shares@ US$8.2921.9% of flowCommon StockSEC:0001104659-22-037153:0
4,100 shares@ US$3.557.6% of flowCommon StockSEC:0001104659-22-025672:0
3,252 shares@ US$3.365.7% of flowCommon StockSEC:0001104659-22-023834:0
20,000 shares0Common StockSEC:0001104659-22-005022:0
3,292 shares@ US$4.956.1% of flowCommon StockSEC:0001104659-21-047689:0
30,000 shares0Common StockSEC:0001104659-21-040307:0
34,000 shares0Common StockSEC:0001104659-21-025273:0
3,186 shares@ US$7.558.8% of flowCommon StockSEC:0001104659-21-023939:0
3,091 shares@ US$8.5112.6% of flowCommon StockSEC:0001104659-20-044247:0
27,500 shares0Common StockSEC:0001104659-20-019455:0
28,125 shares0Common StockSEC:0001104659-19-019772:0
76,494 shares@ US$137.0061.5% of flowCommon StockSEC:0001209191-18-044926:0
28,709 shares@ US$137.0023.1% of flowCommon StockSEC:0001209191-18-044926:1
2,520 shares@ US$136.662.0% of flowCommon StockSEC:0001209191-18-041550:0
8,621 shares@ US$78.753.4% of flowCommon StockSEC:0001209191-18-022887:0
2,344 shares@ US$7.120.1% of flowCommon StockSEC:0001209191-18-022887:1
25 of 48 declarations
